Rating Reports as Figuring Documents

Pénet, Pierre

doi:10.1093/acprof:oso/9780198712282.003.0004

Cited by 6 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In studies of actual business domains or industries, valuation practices usually mean a compound of devices, discourses and practices that make objects, actions or institutions like firms commensurable by the means of calculation, categorization, ranking, and visualization (e.g. Pénet, 2015; Pollock and Campagnolo, 2015; Doganova et al. , 2015; Birch, 2017b; Kornberger, 2017).…”

Section: Theoretical Approach: Valuation Practices In Innovative Tech...mentioning

confidence: 99%

Valuation in emerging technoscience business: a case study of Finnish biobank research

Helén,

Lehtimäki

2023

EJIM

View full text Add to dashboard Cite

PurposeThe paper contributes to the discussion on valuation in organization studies and strategic management literature. The nascent literature on valuation practices has examined established markets where producers and consumers are known and rivalry in the market is a given. Furthermore, previous research has operated with a narrow meaning of value as either a financial profit or a subjective consumer preference. Such a narrow view on value is problematic and insufficient for studying the interlacing of innovation and value creation in emerging technoscientific business domains.Design/methodology/approachThe authors present an empirical study about value creation in an emerging technoscience business domain formed around personalized medicine and digital health data.FindingsThe results of this analysis show that in a technoscientific domain, valuation of innovations is multiple and malleable, entails pursuing attractiveness in collaboration and partnerships and is performative, and due to emphatic future orientation, values are indefinite and promissory.Research limitations/implicationsAs research implications, this study shows that valuation practices in an emerging technoscience business domain focus on defining the potential economic value in the future and attracting partners as probable future beneficiaries. Commercial value upon innovation in an embryonic business milieu is created and situated in valuation practices that constitute the prospective market, the prevalent economic discourse, and rationale. This is in contrast to an established market, where valuation practices are determined at the intersection of customer preferences and competitive arenas where suppliers, producers, service providers and new entrants to the market present value propositions.Practical implicationsThe study findings extend discussion on valuation from established business domains to emerging technoscience business domains which are in a “pre-competition” phase where suppliers, customers, producers and their collaborative and competitive relations are not yet established.Social implicationsAs managerial implications, this study provides insights into health innovation stakeholders, including stakeholders in the public, private and academic sectors, about the ecosystem dynamics in a technoscientific innovation. Such insight is useful in strategic decision-making about ecosystem strategy and ecosystem business model for value proposition, value creation and value capture in an emerging innovation domain characterized by collaborative and competitive relations among stakeholders. To business managers, the findings of this study about valuation practices are useful in strategic decision-making about ecosystem strategy and ecosystem business model for value proposition, value creation and value capture in an emerging innovation domain characterized by collaborative and competitive relations among stakeholders. To policy makers, this study provides an in-depth analysis of an overall business ecosystem in an emerging technoscience business that can be propelled to increase the financial investments in the field. As a policy implication, this study provides insights into the various dimensions of valuation in technoscience business to policy makers, who make governance decisions to guide and control the development of medical innovation using digital health data.Originality/valueThis study's results expand previous theorizing on valuation by showing that in technoscientific innovation all types of value created – scientific, clinical, social or economic – are predominantly promissory. This study complements the nascent theorizing on value creation and valuation practices of technoscientific innovation.

show abstract

Section: Theoretical Approach: Valuation Practices In Innovative Tech...mentioning

confidence: 99%

Valuation in emerging technoscience business: a case study of Finnish biobank research

Helén,

Lehtimäki

2023

EJIM

View full text Add to dashboard Cite

show abstract

“…The framing and fixing of valuations as a mechanism of marketization has important implications for research on the commercialization of science. We complement extant research on the institutions of science commercialization such as property rights (Debackere and Veugelers, ; Lockett and Wright, ; Lockett et al, ), licencing agreements (Lockett and Wright, ; Siegel et al, ) or networks (Baraldi et al, ; Walter et al, ), with understandings of the materials and practices through which valuations are performed (Callon and Muniesa, ; Pénet, ; Pollock and D’Adderio, ). In so doing, we provide a deeper understanding of the co‐ordination and performance of distributed marketization work.…”

Section: Conceptual Interpretation and Theoretical Implicationsmentioning

confidence: 99%

“…It is through valuation practices that the market is ordered, hierarchized, and ultimately valued (Kornberger, ). This seems particularly pertinent in uncertain marketization settings where the anticipatory nature of scientific and market knowledge requires a pragmatic approach to working out what is plausible and what knowledge should be pursued next (Pénet, ), using what devices. The devices used in these valuation practices vary, depending on which actors invoke them and why; we consider these next.…”

Section: Literature Reviewmentioning

confidence: 99%

“…We extend understanding of the commercialization of science by introducing a conceptual framework of choreographed contestations to explain how marketization occurs through the generative interplay of valuation practices and market devices from diverse social worlds. This shifts our attention away from institutional arrangements and towards the practices and devices that perform the collective working out of innovative next steps in the marketization process (Callon and Muniesa, ; Pénet, ; Pollock and D’Adderio, ). These insights take us beyond recognition of the challenges and tensions typically experienced by academic‐entrepreneurs (Siegel and Wright, ; Siegel et al, ), by foregrounding the role of collective valuation practices in ‘ disentangling’ discoveries from extant social worlds and norms in order to make them valuable in markets.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Markets under the Microscope: Making Scientific Discoveries Valuable through Choreographed Contestations

Mason

Friesl

Ford

2018

J Management Studies

View full text Add to dashboard Cite

This paper breaks new ground by revealing and conceptualizing the marketization of science as a process that transforms scientific discoveries and markets through a series of choreographed contestations: moments of valuation that occur when different social worlds collide. We follow a scientific discovery, from the moment it entered an incubator, to uncover how valuation practices and market devices enact and contest diverse social values (i.e., what is worth doing) to generate economic value (i.e., what is worth paying for) at the science‐market‐entrepreneurship nexus. In contrast with commercialization of science studies that focus on institutional arrangements, this study explicates the practices and devices used by multiple market actors to transform a scientific discovery into a marketable object. In so doing, we characterise choreographed contestations and the mechanisms through which they operate to explain how specific valuations are performed to work out innovative next steps that unfold the marketization of science.

show abstract

Knowing-in-Practice, Its Traces and Ingredients

Huvila,

Sköld,

Andersson

2023

The Posthumanist Epistemology of Practice Theory

View full text Add to dashboard Cite

This chapter inquires into how two specific types of epistemic artefacts—traces and ingredients—work together and against each other in conveying understanding of past knowledge-making activities. The discussion draws from an analysis of Swedish and French archaeological investigation reports and from how they, as traces and ingredients, contribute to knowing-in-practice in multiple parallel ways as a part of archaeological practice—literally in practice. Traces and ingredients have different epistemic opportunities and limitations to act as records of the past and goads to action even if many traces can act as ingredients and vice versa albeit with certain limitations that are useful to be aware of. Being aware of how an epistemic artefact works in an epistemic sense—for example as a trace or an ingredient—can help to use them accordingly to what they are capable of, to avoid uses that go against their potential, and to develop better ones.

show abstract

Rating Reports as Figuring Documents

Cited by 6 publications

References 0 publications

Valuation in emerging technoscience business: a case study of Finnish biobank research

Valuation in emerging technoscience business: a case study of Finnish biobank research

Markets under the Microscope: Making Scientific Discoveries Valuable through Choreographed Contestations

Knowing-in-Practice, Its Traces and Ingredients

Contact Info

Product

Resources

About